Psychiatry and Neurology, Epilepsy · Philadelphia, PA
NPI
1861706525
Since 2010
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3400 Civic Center Boulevard, 2nd Floor, South Pavilion
Philadelphia, PA, 19104
Phone (215) 662-3606
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
429 services
Medicare patients, 2024
249
Average age 66
Drug cost, 2024
$1.4M
1,669 prescriptions
Company payments, 2025
$9,951
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Gelfand was code 95720 (neurologic), 108 times for 71 patients. In total Michael A Gelfand billed 429 services in 19 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 108 | 71 | $164.51 | $18K |
| 95816 Neurologic | Facility | 61 | 61 | $42.99 | $2,623 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 51 | 47 | $11.86 | $605 |
| 99214 Office E&M - Established | Facility | 39 | 37 | $58.95 | $2,299 |
| 95718 Neurologic | Facility | 37 | 35 | $104.32 | $3,860 |
| 99215 Office E&M - Established | Facility | 29 | 27 | $100.79 | $2,923 |
| 95819 Neurologic | Facility | 22 | 22 | $38.95 | $857 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 12 | $5.11 | $66.43 |
By year: 2022 $47K for 448 services; 2023 $39K for 371 services; 2024 $37K for 429 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Gelfand prescribed most often to Medicare patients was Lamotrigine Er (Lamotrigine), with 178 prescriptions and refills. In total Michael A Gelfand wrote 1,669 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Er Lamotrigine | 178 | 294 | 33 | $74K |
| Clobazam Generic | 174 | 246 | 37 | $21K |
| Lamotrigine Generic | 143 | 277 | 34 | $3,164 |
| Levetiracetam Generic | 136 | 280 | 41 | $7,009 |
| Lacosamide Generic | 122 | 231 | 32 | $16K |
| Levetiracetam Er Levetiracetam | 106 | 224 | 32 | $7,838 |
| Xcopri Cenobamate | 97 | 143 | 16 | $199K |
| Clonazepam Generic | 63 | 74 | 20 | $715 |
| Divalproex Sodium Er Divalproex Sodium | 56 | 90 | Under 11 | $4,159 |
| Nayzilam Midazolam | 53 | 55 | 21 | $69K |
| Topiramate Generic | 49 | 98 | 12 | $2,477 |
| Oxcarbazepine Generic | 39 | 88 | 14 | $2,179 |
| Zonisamide Generic | 37 | 69 | 11 | $934 |
| Carbamazepine Er Carbamazepine | 30 | 50 | Under 11 | $2,956 |
| Epidiolex Cannabidiol (Cbd) | 28 | 34 | Under 11 | $228K |
Brand drugs: 321 claims; generic drugs: 1,323 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Gelfand $9,951 ($9,951 in general payments such as food, travel and fees) from 6 companies. The largest payer was UCB, Inc. with $7,838.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.